Triple Ring Technologies and 1315 Capital Announce Strategic Growth Partnership
Investors Observer
Triple Ring Technologies (“Triple Ring”), The Co-Development Company for Medical Device and Life Sciences, proudly announces a significant growth capital investment from 1315 Capital, a Philadelphia -based, healthcare-focused growth equity firm. The company was advised by Rob King and Crewe Capital, out of their New York office.
